Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cederquist advises Nordstjernan in connection with public offer for Ramirent

The French equipment rental company Loxam S.A.S (“Loxam”) announced on 10 June 2019 a public takeover bid to the shareholders of the equipment rental company Ramirent Plc, whose shares are listed on Nasdaq Helsinki. Nordstjernan AB owns 21,863,716 shares in Ramirent, corresponding to 20.1 percent of the capital and voting rights in the company, and is thus the largest shareholder of Ramirent. Nordstjernan has undertaken to accept the offer, subject to customary conditions. The offer values Ramirent’s equity at almost EUR 970 million and Nordstjernan’s shareholding in Ramirent at EUR 197

Veidekke ASA: To build more at Straume

Veidekke will build the Grønamyr quarter for Sartor Storsenter AS and Portalen Eiendomsutvikling AS in Kystbyen at Straume. The project comprises 110 apartments, commercial premises and a large roof over the existing goods reception. The contract has an overall value of NOK 230 million, excluding VAT.This construction stage comprises two residential blocks of five and six storeys respectively, commercial premises and a concrete slab over the current goods reception for Sartor Storsenter. One of the residential blocks is for rental and the other is for sale. The homes for sale will be

Revenio Group Corporation - Managers' Transactions

Stock Exchange Release, Managers' Transactions, June 20, 2019 at 14.30Revenio Group Corporation - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Kukkonen AriPosition: Other senior manager(X) Legal personIssuer: Revenio Group CorporationLEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATIONReference number: 743700I27E0FWSXLKK04_20190620140300_2____________________________________________ Transaction date: 2019-06-20Venue: FIRST NORTH FINLAND (FNFI)Instrument type: FINANCIAL

Camurus receives IND acceptance from the FDA to enter Phase 3 with CAM2029 for treatment of acromegaly

Lund, Sweden — 20 June 2019 — Camurus (NASDAQ STO: CAMX), a commercial stage biopharmaceutical company specializing in long-acting medicines for severe and chronic disorders, announced today the acceptance by the US Food and Drug Administration (FDA) of an Investigational New Drug (IND) application to initiate a Phase 3 study with CAM2029 once-monthly octreotide subcutaneous depot for treatment of acromegaly. "We are pleased to receive the IND approval and will now proceed to starting the pivotal Phase 3 study of CAM2029 octreotide subcutaneous depot for the treatment of acromegaly,”

Final patient treated in the phase II part of the ProTrans-1 trial

NextCell Pharma AB (NextCell) today treated the last diabetic patient in the phase II part of the ProTrans-1 trial. This means that all patients included in the clinical study have been treated and are now subject to a 12-month follow-up period before efficacy and safety data will be available.The final patient has been treated in the randomized, placebo controlled ProTrans-1 phase II part trial. Efficacy and safety data will be collected through regular clinical assessments visits during a 12 month period. Last patient, last will be assessed in July 2020 and thereafter the code will be

Cyxone initiates first-in-human trial with T20K for the treatment of MS

Cyxone (publ.), a Swedish biotech in autoimmune diseases, today announced that the company starts its first-in-human, phase I, clinical trial with drug candidate T20K for the treatment of multiple sclerosis (MS) immediately following the authorities’ approval. Currently, the focus is the recruitment and screening of healthy male volunteers for the study.Cyxone’s application to start a first-in-human, phase I, trial with their prophylactic drug candidate T20K targeting multiple sclerosis (MS) has been approved by the accredited Ethics Committee and Central Commission on Research Involving

The Finnish Competition and Consumer Authority initiates further proceedings concerning Caverion’s acquisition of Maintpartner’s operations in Finland, Estonia and Poland

Caverion Corporation Stock exchange release 20 June 2019 at 1.30 p.m. EESTThe Finnish Competition and Consumer Authority initiates further proceedings concerning Caverion’s acquisition of Maintpartner’s operations in Finland, Estonia and Poland Caverion has on 12 March 2019 signed an agreement with Maintpartner Holding Oy to acquire all of the shares in Maintpartner Group Oy including its subsidiaries in Finland, Poland and Estonia. Caverion announced the transaction in a stock exchange release on the same day, as supplemented on 13 March 2019. The transaction is subject to approval by

Feed. the convenient meal

WHAT IS Feed.?                 Feed. offers a range of nutritionally complete meals in a variety ofconvenient formats. Available in bars, bottles, shakers and snackables, Feed.meals provide 100% of your nutritional requirementsfor one meal. Made inFrance using only high-quality ingredients, all Feed. meals are vegan as wellas gluten, lactose, GM and palm oil-free. WHO IS Feed.’s TARGET MARKET? Feed. meals are designed to fit seamlessly into your daily routine. Whetheryou’re in the office, on the move,at the gym or travelling, Feed. offers theperfect alternative to a

BW LPG Company Presentation at Marine Money Week

(Singapore, 18 June 2019) In conjunction with the Marine Money week, BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG”) will be presenting at the 3rd Credit Agricole CIB Shipping Conference in New York on 18 June 2019. Please see the attachment for the full presentation. BW LPG Marine money week Presentation  For further information, please contact: Elaine Ong, CPA, CAChief Financial OfficerBW LPG LimitedTel: +65 6705 5506E-

Construction of Wärtsilä’s Smart Technology Hub starts

Wärtsilä Corporation, News, 20 June 2019 at 1 pm EESTThe technology group Wärtsilä’s Smart Technology Hub project has progressed from planning phase to implementation. The City Council of Vaasa has on the 6th of May approved the area zoning plan as well as the changes in the land subdivision, and the zoning plan has been proclaimed as legitimate on the 14th of June. The Board of Building and Environment has in turn issued the construction permit for the Smart Technology Hub on the 19th of June. Wärtsilä’s partner in the leasing of the real estate and land area is SEB Leasing Oy. The

Byggmax opens new store in Skara

Byggmax opened a new store in Skara this morning. Byggmax continues to grow and now operates a total of 107 stores in Sweden. The new store is located at Hospitalsgatan 7.Byggmax sells construction materials such as lumber, flooring, dry-wall, cement, windows, doors and paint to both professionals and DIY-customers. The Byggmax concept offers good quality products at low prices. Byggmax is part of Byggmax Group, that also includes Skånska Byggvaror and Buildor AB. The corporate group had a turnover of SEK 5.3 billion in 2017 and Byggmax Group is listed on Nasdaq since 2010.

2cureX appoints Dr. Med. Henrik Harling as Chief Medical Officer

2cureX AB (NASDAQ: 2CUREX), a clinical-stage company that has developed the IndiTreat® test allowing individualization of cancer treatment, hereby announces the appointment of Dr. Med. Henrik Harling as Chief Medical Officer (CMO), effective 1. July 2019. In this role, Dr. Harling will oversee the company’s multinational clinical trials, and actively participate in the launch of the IndiTreat® test for individualizing cancer treatment.“Dr. Harling’s comprehensive clinical experience and tremendous international network within the cancer community is of major importance to 2cureX” says Ole

Nexam Chemical publish newsletter

Nexam Chemical has published a newsletter on the company website www.nexamchemical.com .Read, among other things, about how Nexam Chemical create business in China, about the new board members elected at the Annual General Meeting, about customer collaborations as well as the development within the wind power market. The next issue of the newsletter is planned to be published in September 2019. Note: This news has been translated from Swedish. The Swedish text shall govern

Reach Airports Expands its Leadership Team

Taps Krystal J. Brumfield as Chief of StaffReach Airports, a U.S.-based airport management joint venture between Munich Airport International and the Carlyle Group’s CAG Holdings, today announced the appointment of Krystal J. Brumfield as the company’s first Chief of Staff (COS). “Krystal is a well-regarded senior executive in the U.S. airports network. Her deep experience in community development and best business practices based on her legal and legislative background provide the credentials Reach Airports desires to support our aviation clients, connect to communities and move our U.S.

Production update May 2019

Tethys Oil’s share of the production, before government take, from Blocks 3&4 onshore the Sultanate of Oman amounted in May 2019 to 394,650 barrels of oil, corresponding to 12,731 barrels of oil per day.The Official Selling Price (OSP) for Oman Export Blend Crude Oil for the month of May 2019 amounts to USD 66.98 per barrel (1). The OSP, as published by Sultanate of Oman’s Ministry of Oil & Gas, is the benchmark price for Tethys Oil’s monthly oil sales excluding trading and quality adjustments. Tethys Oil AB, through its wholly owned subsidiary Tethys Oil Block 3 & 4 Ltd, has a 30 per

BNP PARIBAS ANNOUNCES NEW APPOINTMENTS IN ITS NORDIC DIVISION TO SUPPORT ITS GROWTH AMBITIONS

Following the announcement in January 2019 of senior appointments, BNP Paribas is continuing to strengthen its position as a leading European bank in the Nordic region with several new appointments in its banking and Asset Management businesses.Marjo Liukkonen Lazaro was appointed as Country Head for Finland on May 1st 2019. In her new role, Marjo is responsible for supporting BNP Paribas’ ambition to strengthen our position as a leading bank in the Nordic region and further drive the expansion of our businesses in Finland.  Heikki Halla joins our Helsinki office as Senior Banker. He

Gunnebo has entered into an agreement to acquire the Czech-based entrance control company Cominfo and announces the intention to carry out a fully underwritten rights issue of MSEK 360

The Gunnebo Group has today signed the acquisition of the Czech company, Cominfo a.s. The acquisition is in line with the Group’s profitable growth strategy and will further strengthen the market position for its Business Unit Entrance Control. In conjunction with the acquisition, Gunnebo announces the intention to carry out a fully underwritten rights issue during the third quarter of 2019.Gunnebo Enters into an Agreement to Acquire Cominfo Cominfo is a Czech-based company offering solutions within entrance control and access systems, where software is an integral part of the offering.

Cancer Research UK chooses Ideagen’s software

The charity will adopt Ideagen’s Q-Pulse and PleaseReview applications for quality management and document review and collaborationIdeagen, the UK-based, global software firm, has secured a new project with a leading cancer charity which will see the company supply it with two of its software applications. Cancer Research UK, the world’s leading cancer charity dedicated to saving lives through research, will implement Ideagen’s Q-Pulse and PleaseReview products. The project will see the charity adopt Ideagen’s software for general quality and compliance management tasks as well as for

SKF acquires cleantech start-up company

Acquisition of RecondOil Sweden AB, a cleantech company working with lubrication fluid and oil filtration will strengthen SKF’s lubrication offerGothenburg, 20 June 2019: SKF has acquired RecondOil Sweden AB, a Swedish cleantech start-up that has developed a chemical filtration and rejuvenation process for industrial lubrication fluid and slop oil. RecondOil’s turnover in 2017 was SEK 10 million and the acquisition will strengthen the Group’s lubrication management business and rotating equipment performance offer. Alrik Danielson, President and CEO, says: “This acquisition is a good

Skanska to build commercial office building in the City of London for about GBP 57.6 M, about SEK 695 M

Skanska will begin work on The Featherstone Building, EC2 in September 2019 for Derwent London. The contract is worth GBP 57.6 M, about SEK 695 M, which will be included in the order bookings for Europe in the second quarter 2019. Work is due to complete in November 2021.This mixed used commercial development, consisting of office and retail space, will have an internal floor area of about 1,160 square meters and a 90-metre-long façade at the front of the building. It is designed to look like four individual office blocks that vary in height and colour. The Featherstone Building is

Stena Line’s Able Seamen Volunteer for Mercy Ships

After a successful volunteer program in 2018, two more employees are preparing for a three-month adventure, joining the Mercy Ships hospital ship ‘Africa Mercy’. In addition to fundraising and raising awareness for the humanitarian NGO, Stena Line also aims to contribute the unique technical and naval competence held by its employees to the work of Mercy Ships. In the next few days two Stena Line Able Seamen, Martina Thowsen and Alexander Gustafsson, will commence their journey in the Las Palmas ship yard where the hospital ship Africa Mercy is scheduled for maintenance before continuing

The subscription period in Scandion Oncology’s rights issue begins today

Today, on the 20th of June, 2019, the subscription period for Scandion Oncology A/S ("Scandion Oncology") rights issue begins. The subscription period runs until the 9th of July 2019. A fully subscribed issue of units will initially provide Scandion Oncology with approximately MSEK 29.3 and an additional approximately MSEK 12.4 (before issue costs) in a later stage if all consideration free warrants are exercised. Ahead of the rights issue, Scandion Oncology has received subscription commitments from, among others, senior executives and board members and also entered into agreements regarding

Ore reserves of keliber’s Syväjärvi deposit increased after new drillings

The mineral reserve and ore reserve estimates for Keliber’s Syväjärvi lithium deposit have been updated. Estimated proven and probable ore reserves total 1.924 million tonnes, which is about 10 percent more than previously estimated.After the publication of the previous Syväjärvi mineral resource estimate in May 2018, the company has continued its drilling program and drilled a total of 8397 meters in the Syväjärvi area. The estimated mineral resources of the Syväjärvi deposit have increased. The JORC 2012 compliant measured and indicated mineral resources of the Syväjärvi deposit, total 2.

There are no items matching the current filter
There are no more items matching the current filter
Back to top